Internazionalization
The HEAL Italia Foundation operates within an international framework to contribute to the development and positioning of the Italian precision medicine and health biotechnology sector within the leading global life sciences ecosystems.
Objectives
Precision medicine currently represents one of the main drivers of innovation in advanced healthcare systems. Its development requires the creation of integrated strategic value chains encompassing genomics, clinical data, artificial intelligence, technological infrastructures, and industrial transfer capabilities. In this context, international cooperation is an essential element to accelerate research, foster innovation, and enhance the value of scientific results.
Within this framework, the HEAL Italia Foundation promotes scientific, technological, and industrial collaborations among universities, research institutions, IRCCS, healthcare organizations, and companies, with a dual objective: to support Italian partners in developing initiatives in international markets, and to attract foreign stakeholders interested in collaborating, investing, or establishing activities in Italy and across Europe.
Through a network involving more than 70 entities, including universities, research centers, clinical institutions, and companies, and through international activities across the United States, Canada, Europe, and Asia, the Foundation operates as a platform connecting research, industry, and the healthcare system, thereby contributing to strengthening the international competitiveness of the Italian precision medicine ecosystem.
Strategic Value Chains
The mapping of facilities and technologies within the HEAL Italia ecosystem, integrated with comparative analyses of the main international precision medicine markets, has made it possible to identify the value chains with the greatest scientific, industrial, and commercial potential. These value chains constitute the strategic reference framework for guiding the Foundation’s international activities, scientific partnerships, and industrial development initiatives.
GENOMICS AND MOLECULAR BIOTECHNOLOGIES
Advanced sequencing, multi-omics analysis, biomarkers, and clinical interpretation of genomic data.
ARTIFICIAL INTELLIGENCE AND HEALTH DATA MANAGEMENT
AI applications in medical imaging, radiomics, predictive models, clinical data interoperability, and decision support systems.
ADVANCED DIAGNOSTICS AND LIQUID BIOPSY
Development of technologies and diagnostic kits for early diagnosis and patient stratification.
INNOVATIVE THERAPIES AND TRANSLATIONAL MEDICINE
Immunotherapy, cell and gene therapies, organoids, and early-phase clinical studies.
MEDICAL DEVICES AND DIGITAL HEALTH TECHNOLOGIES
Advanced medical devices, digital platforms, and integrated solutions for diagnostic and therapeutic pathways.
HEAL Italia Incubator: Facilities, services and Infrastructures
The facilities, services and infrastructures of HEAL Italia represent the Foundation’s principal added value. They derive from the integration of the resources of all partner entities, thereby configuring an integrated ecosystem of extraordinary relevance in terms of the breadth, quality and variety of infrastructures, expertise and, above all, the critical mass of available data.
In this sense, the Foundation stands out as the only entity at national level capable of aggregating and networking such an extensive body of assets, able to interface in a structured manner with the thematic and scientific networks that have been established. The result is a shared infrastructure that constitutes a strategic asset of inestimable value, organised to support and accelerate scientific and technological advancement in the field of precision medicine on an international scale.
BIG DATA MANAGEMENT AND ANALYSIS
IT facilities and platforms for big data management and analysis supporting the activities of the spokes, as well as the management and storage of omics, imaging, clinical and laboratory data.
PREDICTIVE MODELS
Collaborative IT infrastructures for predictive models, developed to maximise the use of open-source software in full compliance with Italian privacy regulations.
APPROFONDISCI >
BIOBANKS
Biobanks and collections of biological samples intended to enable the collection, storage and distribution of biological material according to standardised criteria, in order to ensure the quality of healthcare services provided and accelerate translational research.
PRECLINICAL TESTING SERVICES
Preclinical testing services also aimed at accelerating the proof-of-concept process and the subsequent preclinical validation of new drugs and innovative therapies;
FACILITIES FOR THE PRODUCTION OF ADVANCED THERAPIES (CELL FACTORIES/GMP FACILITIES)
The presence of Cell Factories makes it possible to manufacture Advanced Therapy Medicinal Products in accordance with Good Manufacturing Practice (GMP) standards, one of the new frontiers of medicine, particularly in the regions of Southern Italy;
SERVICES FOR CLINICAL TRIALS
The presence within the partnership of IRCCS, hospitals and their services dedicated to clinical trials (Clinical Trial Centres, etc.) will make it possible to cover all phases of clinical research;
What we offer to those seeking to bring Italian research and innovation abroad
Strategic analysis of international markets
Study of the global dynamics of precision medicine and identification of Countries and Partners with scientific and industrial development potential.
Development of scientific and industrial partnerships
Targeted connections between the areas of excellence of our Italian entities and qualified international partners, in order to foster the joint development of innovative products, services and technologies in the field of precision medicine.
Development of collaborative programmes and international Proofs of Concept
Support for the design and validation of innovative technologies through scientific and industrial collaborations with outstanding partners.
Enhancement of intellectual property
Support in the protection and development of patents and research results, promoting their technology transfer.
What we offer to foreign organisations and companies seeking to enter the Italian precision medicine network
Access to an integrated research and innovation ecosystem
Connection with more than 70 entities, including universities, IRCCS, research centres and companies, as well as access to facilities (biobanks, data analysis platforms, laboratories and specialised clinical infrastructures), networked and ready to be shared for scientific and industrial purposes.
Tailored scientific and industrial partnerships
We identify and connect universities, hospitals, incubators and international companies with our partner entities, building strategic collaborations to jointly develop innovative products and services in precision medicine.
Joint research programmes and Proofs of Concept in Italy
Scientific and industrial collaborations aimed at the development and validation of new technologies.
Support for entry into the European market
Guidance in building partnerships and developing business strategies for entry into the Italian and European markets.
HEAL Italia Activities and Missions
The Foundation’s activities are developed across various international contexts characterised by strong dynamism in the life sciences sector.
In particular:
United States: The leading global biotechnology market and an international hub for research, venture capital and clinical innovation.
Canada: An advanced ecosystem in the integration of genomics, health data and artificial intelligence.
China: A rapidly growing market with significant investments in biomedical technologies and precision medicine.
Japan: A leading country in the development of regenerative medicine and advanced biomedical technologies.
Europe: Scientific and industrial collaborations with various innovation ecosystems in France, Germany, the United Kingdom, Spain and the Nordic countries.
INTERNATIONAL MISSIONS 2026
The Foundation’s internationalisation pathway will continue in 2026 through new institutional missions and participation in the leading global life sciences events.
China: 22–25 April 2026
Japan: 3–16 June 2026
United States: 22–28 June 2026
How to participate
The Foundation is preparing its participation in the BIO International Convention 2026, which will take place in San Diego from 22 to 26 June.
BIO International is the world’s leading event dedicated to biotechnology and each year brings together thousands of companies, research centres and investors from more than 60 countries. Those interested in taking part in the Foundation’s international activities may write to: international@healitalia.com
USA
CANADA
EUROPE
CHINA